ES2310072B1 - Nuevos peptidos determinantes antigenicos t colaboradores (/dth). - Google Patents

Nuevos peptidos determinantes antigenicos t colaboradores (/dth). Download PDF

Info

Publication number
ES2310072B1
ES2310072B1 ES200503169A ES200503169A ES2310072B1 ES 2310072 B1 ES2310072 B1 ES 2310072B1 ES 200503169 A ES200503169 A ES 200503169A ES 200503169 A ES200503169 A ES 200503169A ES 2310072 B1 ES2310072 B1 ES 2310072B1
Authority
ES
Spain
Prior art keywords
baselineskip
hla
peptide
peptides
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES200503169A
Other languages
English (en)
Spanish (es)
Other versions
ES2310072A1 (es
Inventor
Francisco Borras Cuesta
Juan Jose Lasarte Sagastibelza
Marta Ruiz Egozcue
Pablo Sarobe Ugarriza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Proyecto de Biomedicina CIMA SL
Original Assignee
Proyecto de Biomedicina CIMA SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES200503169A priority Critical patent/ES2310072B1/es
Application filed by Proyecto de Biomedicina CIMA SL filed Critical Proyecto de Biomedicina CIMA SL
Priority to AT06841747T priority patent/ATE502047T1/de
Priority to AU2006329789A priority patent/AU2006329789A1/en
Priority to EP06841747A priority patent/EP1978026B1/en
Priority to JP2008546494A priority patent/JP2009520772A/ja
Priority to US12/086,972 priority patent/US20090220533A1/en
Priority to RU2008129731/04A priority patent/RU2008129731A/ru
Priority to CA002634840A priority patent/CA2634840A1/en
Priority to DE602006020781T priority patent/DE602006020781D1/de
Priority to PCT/ES2006/000695 priority patent/WO2007074188A1/es
Priority to BRPI0620243-8A priority patent/BRPI0620243A2/pt
Priority to CNA2006800486390A priority patent/CN101374857A/zh
Publication of ES2310072A1 publication Critical patent/ES2310072A1/es
Application granted granted Critical
Publication of ES2310072B1 publication Critical patent/ES2310072B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES200503169A 2005-12-23 2005-12-23 Nuevos peptidos determinantes antigenicos t colaboradores (/dth). Expired - Fee Related ES2310072B1 (es)

Priority Applications (12)

Application Number Priority Date Filing Date Title
ES200503169A ES2310072B1 (es) 2005-12-23 2005-12-23 Nuevos peptidos determinantes antigenicos t colaboradores (/dth).
DE602006020781T DE602006020781D1 (en) 2005-12-23 2006-12-19 T-helper antigenic determinant (thd) peptide
EP06841747A EP1978026B1 (en) 2005-12-23 2006-12-19 T-helper antigenic determinant (thd) peptides
JP2008546494A JP2009520772A (ja) 2005-12-23 2006-12-19 新規なヘルパーｔ細胞抗原決定基（ｔｈｄ）ペプチド
US12/086,972 US20090220533A1 (en) 2005-12-23 2006-12-19 Novel T-Helper Antigenic Determinant (THD) Peptides
RU2008129731/04A RU2008129731A (ru) 2005-12-23 2006-12-19 Новые пептиды-т-хелперные антигенные детерминанты (thd)
AT06841747T ATE502047T1 (de) 2005-12-23 2006-12-19 T-helper antigenic determinant (thd) peptide
AU2006329789A AU2006329789A1 (en) 2005-12-23 2006-12-19 Novel T-helper antigenic determinant (THD) peptides
PCT/ES2006/000695 WO2007074188A1 (es) 2005-12-23 2006-12-19 NUEVOS PEPTIDOS DETERMINANTES ANTIGENICOS T COLABORADORES (DTh)
BRPI0620243-8A BRPI0620243A2 (pt) 2005-12-23 2006-12-19 peptìdeo quimérico capaz de se ligar à pelo menos uma forma alélica da molécula hla-dr, composição farmaceutica e uso do peptìdeo
CNA2006800486390A CN101374857A (zh) 2005-12-23 2006-12-19 新的t辅助细胞抗原决定簇（thd）肽
CA002634840A CA2634840A1 (en) 2005-12-23 2006-12-19 Novel t-helper antigenic determinant (thd) peptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200503169A ES2310072B1 (es) 2005-12-23 2005-12-23 Nuevos peptidos determinantes antigenicos t colaboradores (/dth).

Publications (2)

Publication Number Publication Date
ES2310072A1 ES2310072A1 (es) 2008-12-16
ES2310072B1 true ES2310072B1 (es) 2009-11-16

Family

ID=38217710

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200503169A Expired - Fee Related ES2310072B1 (es) 2005-12-23 2005-12-23 Nuevos peptidos determinantes antigenicos t colaboradores (/dth).

Country Status (12)

Country Link
US (1) US20090220533A1 (enExample)
EP (1) EP1978026B1 (enExample)
JP (1) JP2009520772A (enExample)
CN (1) CN101374857A (enExample)
AT (1) ATE502047T1 (enExample)
AU (1) AU2006329789A1 (enExample)
BR (1) BRPI0620243A2 (enExample)
CA (1) CA2634840A1 (enExample)
DE (1) DE602006020781D1 (enExample)
ES (1) ES2310072B1 (enExample)
RU (1) RU2008129731A (enExample)
WO (1) WO2007074188A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107375919B (zh) 2009-03-27 2022-07-29 台湾地区“中央研究院” 抗病毒免疫的方法和组合物
TWI537385B (zh) 2010-11-04 2016-06-11 中央研究院 產生具簡單醣基化之表面蛋白質之病毒顆粒的方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995007707A1 (en) * 1993-09-14 1995-03-23 Cytel Corporation Alteration of immune response using pan dr-binding peptides
WO1998032456A1 (en) * 1997-01-23 1998-07-30 Epimmune, Inc. Identification of broadly reactive dr restricted epitopes
US20040236514A1 (en) * 2001-12-13 2004-11-25 Lee Stephen C. Controlling distribution of epitopes in polypeptide sequences

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0876398B1 (en) 1996-01-24 2002-07-17 Epimmune, Inc. Induction of immune response against desired determinants
CA2332786A1 (en) * 1998-05-29 1999-12-02 Epimmune Inc. Identification of broadly reactive dr restricted epitopes
FR2824326B1 (fr) * 2001-05-04 2004-03-19 Commissariat Energie Atomique Melange de peptides issus des proteines e6 et/ou e7 de papillomavirus et leurs applications

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995007707A1 (en) * 1993-09-14 1995-03-23 Cytel Corporation Alteration of immune response using pan dr-binding peptides
WO1998032456A1 (en) * 1997-01-23 1998-07-30 Epimmune, Inc. Identification of broadly reactive dr restricted epitopes
US20040236514A1 (en) * 2001-12-13 2004-11-25 Lee Stephen C. Controlling distribution of epitopes in polypeptide sequences

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ALEXANDER, J., SIDNEY, J., SOUTHWOOD, S. et al. Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. Immunity. Diciembre 1994, Vol. 1, N$^{o}$ 9 páginas 751-761. ISSN 1074-7613. *
BORRÁS-CUESTA, F., GOLVANO, J.-J., GARCÍA-GRANERO, M. et al. Specific and general HLA-DR binding motifs: comparison of algorithms. Human Immunology. 2000, Vol. 61, N$^{o}$ 3, páginas 266-278. ISSN 0198-8859. *

Also Published As

Publication number Publication date
ATE502047T1 (de) 2011-04-15
US20090220533A1 (en) 2009-09-03
EP1978026B1 (en) 2011-03-16
CA2634840A1 (en) 2007-07-05
JP2009520772A (ja) 2009-05-28
WO2007074188A1 (es) 2007-07-05
EP1978026A4 (en) 2010-03-10
EP1978026A1 (en) 2008-10-08
CN101374857A (zh) 2009-02-25
DE602006020781D1 (en) 2011-04-28
AU2006329789A1 (en) 2007-07-05
ES2310072A1 (es) 2008-12-16
RU2008129731A (ru) 2010-01-27
BRPI0620243A2 (pt) 2011-11-08

Similar Documents

Publication Publication Date Title
ES2369055T3 (es) Epítopos de células t auxiliares como estimulantes inmunitarios para inmunógenos peptídicos sintéticos.
ES2318848T3 (es) Peptidos que se unen a pan dr para potenciar la respuesta inmunitaria.
KR100235849B1 (ko) HIV에 대한 면역응답을 유도할 수 있는 펩티드 및 그 펩티드를 함유하는 항 AIDS 예방, 치료제(Peptides Capable of Inducing Immune Response to HIV and Anti-AIDS Agent for Preventing and Curing AIDS)
ES2441118T3 (es) Péptidos modificados hidrófobos derivados de preS del virus de la hepatitis B (HBV), y su uso como inhibidores del acceso del HBV y el HDV
SA519410007B1 (ar) مركبات ببتيد وطرق لمعالجة السكر
CN104903343A (zh) 抗乙型肝炎病毒的疫苗
JP2021509400A (ja) 複数のフラビウイルスの予防および治療を目的としたｍｈｃクラスｉ関連ペプチド
ES2993567T3 (en) Peptides and combinations of peptides for use in immunotherapy against an infection by sars-cov-2 (covid-19)
AU2022201142A1 (en) Vaccine compositions and methods for restoring NKG2D pathway function against cancers
JPH03503166A (ja) 抗ｈｉｖ応答を喚起する合成抗原
BR112020022443A2 (pt) epitopos de células t auxiliares promíscuos artificiais que facilitam a produção de anticorpos alvejados com resposta inflamatória de células t limitada
ES2310072B1 (es) Nuevos peptidos determinantes antigenicos t colaboradores (/dth).
ES2526822T3 (es) Péptidos hsp y análogos para la modulación de respuestas inmunes mediante células presentadoras de antígeno
JP2010029217A (ja) Ｈｉｖ特異的ｃｔｌを誘導し得るペプチド及び該ペプチドを含む抗ａｉｄｓ予防・治療剤
ES2307640T3 (es) Vacunad de adn codificantes de proteinas accesorias del vih.
CN100408595C (zh) Sars病毒hla-a2限制性表位多肽及其应用
CA3220752A1 (en) Improved methods of treatment using immunogenic peptides
WO2022043686A1 (en) Vaccine
MX2008008036A (en) Novel t-helper antigenic determinant (thd) peptides
EP2391748A2 (en) Li-kay hybrid peptides that modulate the immune response to influenza
JPWO2000073465A1 (ja) Ｈｉｖ特異的ｃｔｌを誘導し得るペプチド及び該ペプチドを含む抗ａｉｄｓ予防・治療剤
JPH05506039A (ja) 治療に有用なペプチドおよびペプチド断片
ES2282473T3 (es) Utilizacion de vectores peptidicos para mejorar la respuesta inmunitaria a antigenos.
Ben-Yedidia A peptide-based vaccine against influenza
Levi A synthetic approach to influenza vaccines

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20081216

Kind code of ref document: A1

FD2A Announcement of lapse in spain

Effective date: 20180912